publication Journal Article 2021 Quinazolin-4(3H)-one based Potential Multiple Tyrosine Kinase Inhibitors with Excellent Cytotoxicity, Tebyan O. Mirgany, Ashraf N. Abdalla, Md Arifuzzaman, A. F. M. Motiur Rahman, and Huda S. Al-Salem Anti-cancer drugs J Enzyme Inhib Med Chem. 2021; 36(1): 2055–2067. Publication Work Type Post-Doc. more of publication Quinazolinones, the Winning Horse in Drug Discovery, nazolinones, the Winning Horse in Drug Discovery by Aishah M. Alsibaee, Hanan M. Al-Yousef and Huda S. Al-Salem 2023 Quinazolin-4(3H)-one based Potential Multiple Tyrosine Kinase Inhibitors with Excellent Cytotoxicity, Tebyan O. Mirgany, Ashraf N. Abdalla, Md Arifuzzaman, A. F. M. Motiur Rahman, and Huda S. Al-Salem by Tebyan O. Mirgany, Ashraf N. Abdalla, Md Arifuzzaman, A. F. M. Motiur Rahman, and Huda S. Al-Salem 2021 Isatin-Hydrazones with Multiple Receptor Tyrosine Kinases (RTKs) Inhibitory Activity and In-Silico Binding Mechanism by Huda S. Al-Salem, Md Arifuzzaman, Iman S. Issa, and A. F. M. Motiur Rahman 2021